The role of transmitter diffusion and flow versus extracellular vesicles in volume transmission in the brain neural-glial networks

Philosophical Transactions of the Royal Society B: Biological Sciences

Volumn 370, Issue 1672, 2015, Pages 1-14

  Borroto Escuela, Dasiel O ^a   Agnati, Luigi F ^b   Bechter, Karl ^c   Jansson, Anders ^d   Tarakanov, Alexander O ^e   Fuxe, Kjell ^a  

^a KAROLINSKA INSTITUTE   (Sweden)

^b UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^c UNIVERSITY OF ULM   (Germany)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^e ST PETERSBURG INSTITUTE FOR INFORMATICS AND AUTOMATION   (Russian Federation)

Author keywords

Exosomes; Extracellular vesicles; G protein coupled receptors; Heteroreceptor complexes; Volume transmission; Wiring transmission

Indexed keywords

BODY FLUID; BRAIN; CELL ORGANELLE; CHEMICAL CUE; DIFFUSION; LIPID; MEMBRANE; NEUROLOGY; PROTEIN;

AGENTS INTERACTING WITH TRANSMITTER, HORMONE OR DRUG RECEPTORS;

CELL COMMUNICATION; CELL MEMBRANE; CENTRAL NERVOUS SYSTEM; COMPARATIVE STUDY; DIFFUSION; EXOSOME; GLIA; HUMAN; METABOLISM; NERVE CELL NETWORK; PHYSIOLOGY; SENSORY NERVE CELL;

CELL COMMUNICATION; CELL MEMBRANE; CENTRAL NERVOUS SYSTEM; DIFFUSION; EXTRACELLULAR VESICLES; HUMANS; NERVE NET; NEUROGLIA; NEUROTRANSMITTER AGENTS; SENSORY RECEPTOR CELLS;

EID: 84930974503     PISSN: 09628436     EISSN: 14712970     Source Type: Journal    
DOI: 10.1098/rstb.2014.0183     Document Type: Article

References (127)

1. Fuxe K. 1963 Cellular localization of monoamines in the median eminence and in the infundibular stem of some mammals. Acta Physiol. Scand. 58, 383-384. (doi:10.1111/j.1748-1716.1963.tb02662.x)
2. Fuxe K. 1965 Evidence for the existence of monoamine neurons in the central nervous system. IV. Distribution of monoamine nerve terminals in the central nervous system. Acta Physiol. Scand. Suppl. (Suppl. 247), 237þ.
3. Fuxe K. 1965 Evidence for the existence of monoamine neurons in the central nervous system. 3. The monoamine nerve terminal. Z. Zellforsch. Mik. Ana. 65, 573-596. (doi:10.1007/BF00337069)
4. Dahlstroem A, Fuxe K. 1964 Evidence for the existence of monoamine-containing neurons in the central nervous system. I. Demonstration of monoamines in the cell bodies of brain stem neurons. Acta Physiol. Scand. Suppl. (Suppl. 232), 231-255.
5. Ungerstedt U, Butcher LL, Butcher SG, Anden NE, Fuxe K. 1969 Direct chemical stimulation of dopaminergic mechanisms in the neostriatum of the rat. Brain Res. 14, 461-471. (doi:10.1016/0006-8993(69)90122-X)
6. Fuxe K, Ungerstedt U. 1970 Histochemical, biochemical and functional studies on central monoamine neurons after acute and chronic amphetamine administration. In Amphetamines and related compounds (eds E Costa, S Garattini), pp. 257-288. New York, NY: Raven Press.
7. Agnati LF, Fuxe K, Zoli M, Ozini I, Toffano G, Ferraguti F. 1986 A correlation analysis of the regional distribution of central enkephalin and betaendorphin immunoreactive terminals and of opiate receptors in adult and old male rats. Evidence for the existence of two main types of communication in the central nervous system: the volume transmission and the wiring transmission. Acta Physiol. Scand. 128, 201-207. (doi:10.1111/j.1748-1716.1986.tb07967.x)
8. Fuxe K, Agnati LF, Zoli M, Cintra A, Harfstrand A, von Euler G, Grimaldi R, Kalia M, Eneroth P. 1988 The opioid peptide systems: their organization and role in volume transmission and neuroendocrine regulation. In Regulatory roles of opioid peptides (eds P Illes, C Farsang), pp. 33-68. Weinheim, Germany: VCH.
9. Fuxe K, Hokfelt T, Jonsson G, Ungerstedt U. 1970 Fluorescence microscopy in neuroanatomy. In Contemporary research methods in neuroanatomy (eds WJH Nauta, SOE Ebbesson), pp. 275-314. Berlin, Germany: Springer.
10. De-Miguel FF, Trueta C. 2005 Synaptic and extrasynaptic secretion of serotonin. Cell. Mol. Neurobiol. 25, 297-312. (doi:10.1007/s10571-005-3061-z)
11. Trueta C, De-Miguel FF. 2012 Extrasynaptic exocytosis and its mechanisms: a source of molecules mediating volume transmission in the nervous system. Front. Physiol. 3, 319. (doi:10.3389/fphys.2012.00319)
12. Fuxe K, Agnati LF. 1991 Volume transmission in the brain, novel mechanisms for neural transmission. New York, NY: Raven Press.
13. Agnati LF, Fuxe K, Nicholson C, Sykova E. 2000 Volume transmission revisited. Amsterdam, The Netherlands: Elsevier Science BV
14. Agnati LF, Guidolin D, Guescini M, Genedani S, Fuxe K. 2010 Understanding wiring and volume transmission. Brain Res. Rev. 64, 137-159. (doi:10.1016/j.brainresrev.2010.03.003)
15. Fuxe K, Dahlstrom AB, Jonsson G, Marcellino D, Guescini M, Dam M, Manger P, Agnati L. 2010 The discovery of central monoamine neurons gave volume transmission to the wired brain. Progr. Neurobiol. 90, 82-100. (doi:10.1016/j.pneurobio.2009.10.012)
16. Fuxe K et al. 2012 Extrasynaptic neurotransmission in the modulation of brain function. Focus on the striatal neuronal-glial networks. Front. Physiol. 3, 136. (doi:10.3389/fphys.2012.00136)
17. Fuxe K, Borroto-Escuela DO, Romero-Fernandez W, Ciruela F, Manger P, Leo G, Diaz-Cabiale Z, Agnati LF. 2012 On the role of volume transmission and receptor-receptor interactions in social behaviour: focus on central catecholamine and oxytocin neurons. Brain Res. 1476, 119-131. (doi:10.1016/j.brainres.2012.01.062)
18. De-Miguel FF, Fuxe K. 2012 Extrasynaptic neurotransmission as a way of modulating neuronal functions. Front. Physiol. 3, 16. (doi:10.3389/fphys.2012.00016)
19. Agnati LF, Fuxe K. 2014 Extracellular-vesicle type of volume transmission and tunnelling-nanotube type of wiring transmission add a new dimension to brain neuro-glial networks. Phil. Trans. R. Soc. B 369, 20130505. (doi:10.1098/rstb.2013.0505)
20. Simons M, Raposo G. 2009 Exosomes—vesicular carriers for intercellular communication. Curr. Opin. Cell Biol. 21, 575-581. (doi:10.1016/j.ceb.2009.03.007)
21. Agnati LF, Cortelli P, Pettersson R, Fuxe K. 1995 The concept of trophic units in the central nervous system. Progr. Neurobiol. 46, 561-574. (doi:10.1016/0301-0082(95)00017-P)
22. Fuxe K, Marcellino D, Genedani S, Agnati LF. 2007 Adenosine A(2A) receptors, dopamine D(2) receptors and their interactions in Parkinson’s disease. Mov. Disord. 22, 1990-2017. (doi:10.1002/mds.21440)
23. Fuxe K et al. 2013 Understanding the balance and integration of volume and synaptic transmission. Relevance for psychiatry. Fortschr. Neurol. Psyc. 19, 141-158. (doi:10.1016/j.npbr.2013.10.002)
24. Fuxe K, Borroto-Escuela DO, Ciruela F, Guidolin D, Agnati LF. 2014 Receptor-receptor interactions in heteroreceptor complexes: a new principle in biology. Focus on their role in learning and memory. Neurosci. Disc. 2, 6. (doi:10.7243/2052-6946-2-6)
25. Borroto-Escuela DO, Romero-Fernandez W, Narvaez M, Oflijan J, Agnati LF, Fuxe K. 2014 Hallucinogenic 5-HT2AR agonists LSD and DOI enhance dopamine D2R protomer recognition and signaling of D2-5-HT2A heteroreceptor complexes. Biochem. Biophys. Res. Commun. 443, 278-284. (doi:10.1016/j.bbrc.2013.11.104)
26. Fuxe K, Borroto-Escuela DO, Tarakanov AO, Romero-Fernandez W, Ferraro L, Tanganelli S, Perez-Alea M, Di Palma M, Agnati LF. 2014 Dopamine D2 heteroreceptor complexes and their receptor-receptor interactions in ventral striatum: novel targets for antipsychotic drugs. Progr. Brain Res. 211, 113-139. (doi:10.1016/B978-0-444-63425-2.00005-2)
27. Borroto-Escuela DO et al. 2012 Fibroblast growth factor receptor 1-5-hydroxytryptamine 1A heteroreceptor complexes and their enhancement of hippocampal plasticity. Biol. Psychiatry 71, 84-91. (doi:10.1016/j.biopsych.2011.09.012)
28. Del Arco A, Segovia G, Fuxe K, Mora F. 2003 Changes in dialysate concentrations of glutamate and GABA in the brain: an index of volume transmission mediated actions? J. Neurochem. 85, 23-33. (doi:10.1046/j.1471-4159.2003.01692.x)
29. Theodosis DT, Chapman DB, Montagnese C, Poulain DA, Morris JF. 1986 Structural plasticity in the hypothalamic supraoptic nucleus at lactation affects oxytocin-, but not vasopressin-secreting neurones. Neuroscience 17, 661-678. (doi:10.1016/0306-4522(86)90038-2)
30. Piet R, Vargova L, Sykova E, Poulain DA, Oliet SH. 2004 Physiological contribution of the astrocytic environment of neurons to intersynaptic crosstalk. Proc. Natl Acad. Sci. USA 101, 2151-2155. (doi:10.1073/pnas.0308408100)
31. Oliet SH, Panatier A, Piet R, Mothet JP, Poulain DA, Theodosis DT. 2008 Neuron-glia interactions in the rat supraoptic nucleus. Progr. Brain Res. 170, 109-117. (doi:10.1016/S0079-6123(08)00410-X)
32. Murphy-Royal C, Dupuis JP, Varela JA, Panatier A, Pinson B, Baufreton J, Groc L, Oliet SH. 2015 Surface diffusion of astrocytic glutamate transporters shapes synaptic transmission. Nat. Neurosci. 18, 219-226. (doi:10.1038/nn.3901)
33. Fuxe K et al. 2007 From the Golgi-Cajal mapping to the transmitter-based characterization of the neuronal networks leading to two modes of brain communication: wiring and volume transmission. Brain Res. Rev. 55, 17-54. (doi:10.1016/j.brainresrev.2007.02.009)
34. Descarries L, Mechawar N. 2000 Ultrastructural evidence for diffuse transmission by monoamine and acetylcholine neurons of the central nervous system. Progr. Brain Res. 125, 27-47. (doi:10.1016/S0079-6123(00)25005-X)
35. Descarries L, Watkins KC, Garcia S, Bosler O, Doucet G. 1996 Dual character, asynaptic and synaptic, of the dopamine innervation in adult rat neostriatum: a quantitative autoradiographic and immunocytochemical analysis. J. Comp. Neurol. 375, 167-186. (doi:10.1002/(SICI)1096-9861(19961111)375:2,167:AID-CNE1.3. 0.CO;2-0)
36. Rice ME, Cragg SJ. 2008 Dopamine spillover after quantal release: rethinking dopamine transmission in the nigrostriatal pathway. Brain Res. Rev. 58, 303-313. (doi:10.1016/j.brainresrev.2008.02.004)
37. Bjelke B, England R, Nicholson C, Rice ME, Lindberg J, Zoli M, Agnati LF, Fuxe K. 1995 Long distance pathways of diffusion for dextran along fibre bundles in brain. Relevance for volume transmission. Neuroreport 6, 1005-1009. (doi:10.1097/00001756-199505090-00014)
38. Jansson A et al. 1999 On the distribution patterns of D1, D2, tyrosine hydroxylase and dopamine transporter immunoreactivities in the ventral striatum of the rat. Neuroscience 89, 473-489. (doi:10.1016/S0306-4522(98)00317-0)
39. Fuxe K, Borroto-Escuela DO, Romero-Fernandez W, Zhang WB, Agnati LF. 2013 Volume transmission and its different forms in the central nervous system. Chin. J. Integr. Med. 19, 323-329. (doi:10.1007/s11655-013-1455-1)
40. Agnati LF, Genedani S, Lenzi PL, Leo G, Mora F, Ferre S, Fuxe K. 2005 Energy gradients for the homeostatic control of brain ECF composition and for VT signal migration: introduction of the tide hypothesis. J. Neural Transm. 112, 45-63. (doi:10.1007/s00702-004-0180-5)
41. Hoistad M, Samskog J, Jacobsen KX, Olsson A, Hansson HA, Brodin E, Fuxe K. 2005 Detection of beta-endorphin in the cerebrospinal fluid after intrastriatal microinjection into the rat brain. Brain Res. 1041, 167-180. (doi:10.1016/j.brainres.2005. 02.014)
42. Jansson A, Lippoldt A, Mazel T, Bartfai T, Ogren SO, Sykova E, Agnati LF, Fuxe K. 2000 Long distance signalling in volume transmission. Focus on clearance mechanisms. Progr. Brain Res. 125, 399-413. (doi:10.1016/S0079-6123(00)25028-0)
43. van der Pol E, Boing AN, Harrison P, Sturk A, Nieuwland R. 2012 Classification, functions, and clinical relevance of extracellular vesicles. Pharmacol. Rev. 64, 676-705. (doi:10.1124/pr.112.005983)
44. Leon-Pinzon C, Cercos MG, Noguez P, Trueta C, De-Miguel FF. 2014 Exocytosis of serotonin from the neuronal soma is sustained by a serotonin and calcium-dependent feedback loop. Front. Cell. Neurosci. 8, 169. (doi:10.3389/fncel.2014.00169)
45. Faure J et al. 2006 Exosomes are released by cultured cortical neurones. Mol. Cell. Neurosci. 31, 642-648. (doi:10.1016/j.mcn.2005.12.003)
46. Guescini M et al. 2012 Microvesicle and tunneling nanotube mediated intercellular transfer of g-protein coupled receptors in cell cultures. Exp. Cell Res. 318, 603-613. (doi:10.1016/j.yexcr.2012.01.005)
47. Chivet M, Javalet C, Hemming F, Pernet-Gallay K, Laulagnier K, Fraboulet S, Sadoul R. 2013 Exosomes as a novel way of interneuronal communication. Biochem. Soc. Trans. 41, 241-244. (doi:10.1042/BST20120266)
48. Lachenal G et al. 2011 Release of exosomes from differentiated neurons and its regulation by synaptic glutamatergic activity. Mol. Cell. Neurosci. 46, 409-418. (doi:10.1016/j.mcn.2010.11.004)
49. Pocock JM, Kettenmann H. 2007 Neurotransmitter receptors on microglia. Trends Neurosci. 30, 527-535. (doi:10.1016/j.tins.2007.07.007)
50. Kettenmann H, Hanisch UK, Noda M, Verkhratsky A. 2011 Physiology of microglia. Physiol. Rev. 91, 461-553. (doi:10.1152/physrev.00011.2010)
51. Bechter K, Reiber H, Herzog S, Fuchs D, Tumani H, Maxeiner HG. 2010 Cerebrospinal fluid analysis in affective and schizophrenic spectrum disorders: identification of subgroups with immune responses and blood-CSF barrier dysfunction. J. Psychiatr. Res. 44, 321-330. (doi:10.1016/j.jpsychires.2009.08. 008)
52. Bechter K. 2013 Updating the mild encephalitis hypothesis of schizophrenia. Progr. Neuropsychopharmacol. Biol. Psychiatry 42, 71-91. (doi:10.1016/j.pnpbp.2012.06.019)
53. Bechter K. 2013 Schizophrenia—a mild encephalitis?. Fortschr. Neurol. Psychiatr. 81, 250-259. (doi:10.1055/s-0033-1335253)
54. Prada I, Furlan R, Matteoli M, Verderio C. 2013 Classical and unconventional pathways of vesicular release in microglia. Glia 61, 1003-1017. (doi:10.1002/glia.22497)
55. Kettenmann H, Kirchhoff F, Verkhratsky A. 2013 Microglia: new roles for the synaptic stripper. Neuron 77, 10-18. (doi:10.1016/j.neuron.2012.12.023)
56. Schwartz M, Baruch K. 2014 Breaking peripheral immune tolerance to CNS antigens in neurodegenerative diseases: boosting autoimmunity to fight-off chronic neuroinflammation. J. Autoimmunity 54C, 8-14. (doi:10.1016/j.jaut.2014.08.002)
57. Schwartz M, Baruch K. 2014 The resolution of neuroinflammation in neurodegeneration: leukocyte recruitment via the choroid plexus. EMBO J. 33, 7-22. (doi:10.1002/embj.201386609)
58. Lippoldt A, Liebner S, Andbjer B, Kalbacher H, Wolburg H, Haller H, Fuxe K. 2000 Organization of choroid plexus epithelial and endothelial cell tight junctions and regulation of claudin-1, -2 and -5 expression by protein kinase C. Neuroreport 11, 1427-1431. (doi:10.1097/00001756-200005150-00015)
59. Lippoldt A, Jansson A, Kniesel U, Andbjer B, Andersson A, Wolburg H, Fuxe K, Haller H. 2000 Phorbol ester induced changes in tight and adherens junctions in the choroid plexus epithelium and in the ependyma. Brain Res. 854, 197-206. (doi:10.1016/S0006-8993(99)02355-0)
60. Horvath TL, Warden CH, Hajos M, Lombardi A, Goglia F, Diano S. 1999 Brain uncoupling protein 2: uncoupled neuronal mitochondria predict thermal synapses in homeostatic centers. J. Neurosci. 19, 10 417-10 427.
61. Fuxe K, Rivera A, Jacobsen KX, Hoistad M, Leo G, Horvath TL, Staines W, De la Calle A, Agnati LF. 2005 Dynamics of volume transmission in the brain. Focus on catecholamine and opioid peptide communication and the role of uncoupling protein 2. J. Neural Transm. 112, 65-76. (doi:10.1007/s00702-004-0158-3)
62. Wang H et al. 2014 Brain temperature and its fundamental properties: a review for clinical neuroscientists. Front. Neurosci. 8, 307. (doi:10.3389/fnins.2014.00307)
63. Zoli M, Jansson A, Sykova E, Agnati LF, Fuxe K. 1999 Volume transmission in the CNS and its relevance for neuropsychopharmacology. Trends Pharmacol. Sci. 20, 142-150. (doi:10.1016/S0165-6147(99)01343-7)
64. Iliff JJ et al. 2012 A paravascular pathway facilitates CSF flow through the brain parenchyma and the clearance of interstitial solutes, including amyloid beta. Sci. Transl. Med. 4, 111-147. (doi:10.1126/scitranslmed.3003748)
65. Nedergaard M. 2013 Neuroscience. Garbage truck of the brain. Science 340, 1529-1530. (doi:10.1126/science.1240514)
66. Walz W, Hertz L. 1983 Comparison between fluxes of potassium and of chloride in astrocytes in primary cultures. Brain Res. 277, 321-328. (doi:10.1016/0006-8993(83)90940-X)
67. Walz W. 2000 Role of astrocytes in the clearance of excess extracellular potassium. Neurochem. Int. 36, 291-300. (doi:10.1016/S0197-0186(99)00137-0)
68. Kofuji P, Newman EA. 2004 Potassium buffering in the central nervous system. Neuroscience 129, 1045-1056. (doi:10.1016/j.neuroscience.2004.06.008)
69. Peppiatt CM, Howarth C, Mobbs P, Attwell D. 2006 Bidirectional control of CNS capillary diameter by pericytes. Nature 443, 700-704. (doi:10.1038/nature05193)
70. Hall CN et al. 2014 Capillary pericytes regulate cerebral blood flow in health and disease. Nature 508, 55-60. (doi:10.1038/nature13165)
71. Xie L et al. 2013 Sleep drives metabolite clearance from the adult brain. Science 342, 373-377. (doi:10.1126/science.1241224)
72. Fuxe K, Agnati LF, Benfenati F, Celani M, Zini I, Zoli M, Mutt V. 1983 Evidence for the existence of receptor-receptor interactions in the central nervous system. Studies on the regulation of monoamine receptors by neuropeptides. J. Neural Transm. Suppl. 18, 165-179.
73. Zoli M, Agnati LF, Hedlund PB, Li XM, Ferre S, Fuxe K. 1993 Receptor-receptor interactions as an integrative mechanism in nerve cells. Mol. Neurobiol. 7, 293-334. (doi:10.1007/BF02769180)
74. Fuxe K, Agnati LF, Borroto-Escuela DO. 2014 The impact of receptor-receptor interactions in heteroreceptor complexes on brain plasticity. Expert Rev. Neurother. 14, 719-721. (doi:10.1586/14737175.2014.922878)
75. George SR, Kern A, Smith RG, Franco R. 2014 Dopamine receptor heteromeric complexes and their emerging functions. Progr. Brain Res. 211, 183-200. (doi:10.1016/B978-0-444-63425-2.00008-8)
76. Perreault ML, O’Dowd BF, George SR. 2014 Dopamine D(1)-D(2) receptor heteromer regulates signaling cascades involved in addiction: potential relevance to adolescent drug susceptibility. Dev. Neurosci. 36, 287-296. (doi:10.1159/000360158)
77. Fuxe K et al. 2003 Receptor heteromerization in adenosine A2A receptor signaling: relevance for striatal function and Parkinson’s disease. Neurology 61(Suppl. 6), S19-S23. (doi:10.1212/01.WNL. 0000095206.44418.5C)
78. Agnati LF, Ferre S, Lluis C, Franco R, Fuxe K. 2003 Molecular mechanisms and therapeutical implications of intramembrane receptor/receptor interactions among heptahelical receptors with examples from the striatopallidal GABA neurons. Pharmacol. Rev. 55, 509-550. (doi:10.1124/pr.55.3.2)
79. Fuxe K, Marcellino D, Borroto-Escuela DO, Guescini M, Fernandez-Duenas V, Tanganelli S, Rivera A, Ciruela F, Agnati LF. 2010 Adenosine-dopamine interactions in the pathophysiology and treatment of CNS disorders. CNS Neurosci. Therap. 16, e18-e42. (doi:10.1111/j.1755-5949.2009.00126.x)
80. Jeffery CJ. 1999 Moonlighting proteins. Trends Biochem. Sci. 24, 8-11. (doi:10.1016/S0968-0004(98)01335-8)
81. Jeffery CJ. 2014 An introduction to protein moonlighting. Biochem. Soc. Trans. 42, 1679-1683. (doi:10.1042/BST20140226)
82. Borroto-Escuela DO, Tarakanov AO, Guidolin D, Ciruela F, Agnati LF, Fuxe K. 2011 Moonlighting characteristics of G protein-coupled receptors: focus on receptor heteromers and relevance for neurodegeneration. IUBMB Life 63, 463-472. (doi:10.1002/iub.473)
83. Fuxe K et al. 2012 GPCR heteromers and their allosteric receptor-receptor interactions. Curr. Med. Chem. 19, 356-363. (doi:10.2174/092986712803414259)
84. Fuxe K, Borroto-Escuela DO, Romero-Fernandez W, Palkovits M, Tarakanov AO, Ciruela F, Agnati LF. 2014 Moonlighting proteins and protein-protein interactions as neurotherapeutic targets in the G protein-coupled receptor field. Neuropsychopharmacology 39, 131-155. (doi:10.1038/npp.2013.242)
85. Borroto-Escuela DO, Romero-Fernandez W, Tarakanov AO, Ciruela F, Agnati LF, Fuxe K. 2011 On the existence of a possible A2A-D2-beta-Arrestin2 complex: A2A agonist modulation of D2 agonistinduced beta-arrestin2 recruitment. J. Mol. Biol. 406, 687-699. (doi:10.1016/j.jmb.2011.01.022)
86. Hasbi A, O’Dowd BF, George SR. 2011 Dopamine D1-D2 receptor heteromer signaling pathway in the brain: emerging physiological relevance. Mol. Brain 4, 26. (doi:10.1186/1756-6606-4-26)
87. Borroto-Escuela DO, Flajolet M, Agnati LF, Greengard P, Fuxe K. 2013 Bioluminescence resonance energy transfer methods to study g protein-coupled receptor-receptor tyrosine kinase heteroreceptor complexes. Methods Cell Biol. 117, 141-164. (doi:10.1016/B978-0-12-408143-7.00008-6)
88. Borroto-Escuela DO, Corrales F, Narvaez M, Oflijan J, Agnati LF, Palkovits M, Fuxe K. 2013 Dynamic modulation of FGFR1-5-HT1A heteroreceptor complexes. Agonist treatment enhances participation of FGFR1 and 5-HT1A homodimers and recruitment of beta-arrestin2. Biochem. Biophys. Res. Commun. 441, 387-392. (doi:10.1016/j.bbrc.2013. 10.067)
89. Borroto-Escuela DO, Romero-Fernandez W, Garriga P, Ciruela F, Narvaez M, Tarakanov AO, Palkovits M, Agnati LF, Fuxe K. 2013 G protein-coupled receptor heterodimerization in the brain. Methods Enzymol. 521, 281-294. (doi:10.1016/B978-0-12-391862-8.00015-6)
90. Borroto-Escuela DO et al. 2015 Evidence for the existence of FGFR1-5-HT1A heteroreceptor complexes in the midbrain raphe 5-HT system. Biochem. Biophys. Res. Commun. 456, 489-493. (doi:10.1016/j.bbrc.2014.11.112)
91. Flajolet M et al. 2008 FGF acts as a co-transmitter through adenosine A(2A) receptor to regulate synaptic plasticity. Nat. Neurosci. 11, 1402-1409. (doi:10.1038/nn.2216)
92. Lee FJ et al. 2002 Dual regulation of NMDA receptor functions by direct protein-protein interactions with the dopamine D1 receptor. Cell 111, 219-230. (doi:10.1016/S0092-8674(02)00962-5)
93. Liu XY et al. 2006 Modulation of D2R-NR2B interactions in response to cocaine. Neuron 52, 897-909. (doi:10.1016/j.neuron.2006.10.011)
94. Wang M, Wong AH, Liu F. 2012 Interactions between NMDA and dopamine receptors: a potential therapeutic target. Brain Res. 1476, 154-163. (doi:10.1016/j.brainres.2012.03.029)
95. Lee FJ, Wang YT, Liu F. 2005 Direct receptor crosstalk can mediate the modulation of excitatory and inhibitory neurotransmission by dopamine. J. Mol. Neurosci. 26, 245-252. (doi:10.1385/JMN:26:2-3:245)
96. Zou S, Li L, Pei L, Vukusic B, Van Tol HH, Lee FJ, Wan Q, Liu F. 2005 Protein-protein coupling/uncoupling enables dopamine D2 receptor regulation of AMPA receptor-mediated excitotoxicity. J. Neurosci. 25, 4385-4395. (doi:10.1523/JNEUROSCI.5099-04.2005)
97. Nai Q, Li S, Wang SH, Liu J, Lee FJ, Frankland PW, Liu F. 2010 Uncoupling the D1-N-methyl-Daspartate (NMDA) receptor complex promotes NMDA-dependent long-term potentiation and working memory. Biol. Psychiatry 67, 246-254. (doi:10.1016/j.biopsych.2009.08.011)
98. Borroto-Escuela DO et al. 2010 Characterization of the A2AR-D2R interface: focus on the role of the Cterminal tail and the transmembrane helices. Biochem. Biophys. Res. Commun. 402, 801-807. (doi:10.1016/j.bbrc.2010.10.122)
99. Borroto-Escuela DO, Marcellino D, Narvaez M, Flajolet M, Heintz N, Agnati L, Ciruela F, Fuxe K. 2010 A serine point mutation in the adenosine A2AR C-terminal tail reduces receptor heteromerization and allosteric modulation of the dopamine D2R. Biochem. Biophys. Res. Commun. 394, 222-227. (doi:10.1016/j.bbrc.2010.02.168)
100. O’Dowd BF, Ji X, Nguyen T, George SR. 2012 Two amino acids in each of D1 and D2 dopamine receptor cytoplasmic regions are involved in D1-D2 heteromer formation. Biochem. Biophys. Res. Commun. 417, 23-28. (doi:10.1016/j.bbrc.2011.11.027)
101. Tarakanov AO, Fuxe KG. 2010 Triplet puzzle: homologies of receptor heteromers. J. Mol. Neurosci. 41, 294-303. (doi:10.1007/s12031-009-9313-5)
102. Tarakanov AO, Fuxe KG, Borroto-Escuela DO. 2012 Integrin triplets of marine sponges in human brain receptor heteromers. J. Mol. Neurosci. 48, 154-160. (doi:10.1007/s12031-012-9793-6)
103. Tarakanov AO, Fuxe KG, Borroto-Escuela DO. 2012 On the origin of the triplet puzzle of homologies in receptor heteromers: immunoglobulin triplets in different types of receptors. J. Mol. Neurosci. 46, 616-621. (doi:10.1007/s12031-011-9649-5)
104. Tarakanov AO, Fuxe KG, Borroto-Escuela DO. 2012 On the origin of the triplet puzzle of homologies in receptor heteromers: Toll-like receptor triplets in different types of receptors. J. Neural Transm. 119, 517-523. (doi:10.1007/s00702-011-0734-2)
105. Liu F, Wan Q, Pristupa ZB, Yu XM, Wang YT, Niznik HB. 2000 Direct protein-protein coupling enables cross-talk between dopamine D5 and gammaaminobutyric acid A receptors. Nature 403, 274-280. (doi:10.1038/35002014)
106. Kenakin T, Miller LJ. 2010 Seven transmembrane receptors as shapeshifting proteins: the impact of allosteric modulation and functional selectivity on new drug discovery. Pharmacol. Rev. 62, 265-304. (doi:10.1124/pr.108.000992)
107. Maudsley S. 2012 G protein-coupled receptor biased agonism: development towards future selective therapeutics. Mini Rev. Med. Chem. 12, 803. (doi:10.2174/138955712800959161)
108. Maudsley S, Patel SA, Park SS, Luttrell LM, Martin B. 2012 Functional signaling biases in G proteincoupled receptors: game theory and receptor dynamics. Mini Rev. Med. Chem. 12, 831-840. (doi:10.2174/138955712800959071)
109. Fuxe K et al. 2014 Diversity and bias through receptor-receptor interactions in GPCR heteroreceptor complexes. Focus on examples from dopamine D2 receptor heteromerization. Front. Endocrinol. 5, 71. (doi:10.3389/fendo.2014.00071)
110. Fuxe K, Ungerstedt U. 1967 Localization of 5-hydroxytryptamine uptake in rat brain after intraventricular injection. J. Pharmacy Pharmacol. 19, 335-337. (doi:10.1111/j.2042-7158.1967.tb08097.x)
111. Carlsson A, Fuxe K, Ungerstedt U. 1968 The effect of imipramine on central 5-hydroxytryptamine neurons. J. Pharmacy Pharmacol. 20, 150-151.(doi:10.1111/j.2042-7158.1968.tb09706.x)
112. Fuxe K, Hedlund P, Von Euler G, Lundgren K, Martire M, Ogren SO, Eneroth P, Agnati L. 1991 Galanin/5-HT interactions in the rat central nervous system. Relevance for depression. In Galanin: A new multifunctional peptide in the neuroendocrine system (eds T Hokfelt, T Bartfai, DM Jocobowitz, D Ottoson), pp. 221-235. London, UK: MacMillan Press.
113. Fuxe K, Ogren SO, Agnati L, Gustafsson JA, Jonsson G. 1977 On the mechanism of action of the antidepressant drugs amitriptyline and nortriptyline. Evidence for 5-hydroxytryptamine receptor blocking activity. Neurosci. Lett. 6, 339-343. (doi:10.1016/0304-3940(77)90095-7)
114. Borroto-Escuela DO, Narvaez M, Marcellino D, Parrado C, Narvaez JA, Tarakanov AO, Agnati LF, Diaz-Cabiale Z, Fuxe K. 2010 Galanin receptor-1 modulates 5-hydroxtryptamine-1A signaling via heterodimerization. Biochem. Biophys. Res. Commun. 393, 767-772. (doi:10.1016/j.bbrc.2010.02.078)
115. Hamon M, Blier P. 2013 Monoamine neurocircuitry in depression and strategies for new treatments. Progr. Neuro-Psychopharmacol. Biol. Psychiatry 45, 54-63. (doi:10.1016/j.pnpbp.2013.04.009)
116. Pancer Z, Kruse M, Muller I, Muller WE. 1997 On the origin of Metazoan adhesion receptors: cloning of integrin alpha subunit from the sponge Geodia cydonium. Mol. Biol. Evol. 14, 391-398. (doi:10.1093/oxfordjournals.molbev.a025775)
117. El-Asmar L, Springael JY, Ballet S, Andrieu EU, Vassart G, Parmentier M. 2005 Evidence for negative binding cooperativity within CCR5-CCR2b heterodimers. Mol. Pharmacol. 67, 460-469. (doi:10.1124/mol.104.003624)
118. Fuxe K et al. 2008 Receptor-receptor interactions within receptor mosaics. Impact on neuropsychopharmacology. Brain Res. Rev. 58, 415-452. (doi:10.1016/j.brainresrev.2007.11.007)
119. Renner U et al. 2012 Heterodimerization of serotonin receptors 5-HT1A and 5-HT7 differentially regulates receptor signalling and trafficking. J. Cell Sci. 125, 2486-2499. (doi:10.1242/jcs.101337)
120. Jansson A, Tinner B, Bancila M, Verge D, Steinbusch HW, Agnati LF, Fuxe K. 2001 Relationships of 5-hydroxytryptamine immunoreactive terminal-like varicosities to 5-hydroxytryptamine-2A receptorimmunoreactive neuronal processes in the rat forebrain. J. Chem. Neuroanat. 22, 185-203. (doi:10.1016/S0891-0618(01)00133-8)
121. Steinbusch HW. 1981 Distribution of serotoninimmunoreactivity in the central nervous system of the rat-cell bodies and terminals. Neuroscience 6, 557-618. (doi:10.1016/0306-4522(81)90146-9)
122. Albert PR, Le Francois B, Millar AM. 2011 Transcriptional dysregulation of 5-HT1A autoreceptors in mental illness. Mol. Brain 4, 21. (doi:10.1186/1756-6606-4-21)
123. Fuxe K, Marcellino D, Woods AS, Giuseppina L, Antonelli T, Ferraro L, Tanganelli S, Agnati LF. 2009 Integrated signaling in heterodimers and receptor mosaics of different types of GPCRs of the forebrain: relevance for schizophrenia. J. Neural Transm. 116, 923-939. (doi:10.1007/s00702-008-0174-9)
124. Bechter K. 2011 The peripheral cerebrospinal fluid outflow pathway—physiology and pathophysiology of CSF recirculation: a review and hypothesis. Fortschr. Neurol. Psychiatr. 17, 51-66. (doi:10.1016/j.npbr.2011.06.003)
125. Smythies J. 2015 Off the beaten track: the molecular structure of long-term memory: three novel hypotheses—electrical, chemical and anatomical (allosteric). Front. Integr. Neurosci. 9, 4. (doi:10.3389/fnint.2015.00004)
126. Priel A, Tuszynski JA, Woolf NJ. 2010 Neural cytoskeleton capabilities for learning and memory. J. Biol. Phys. 36, 3-21. (doi:10.1007/s10867-009-9153-0)
127. Plankar M, Brezan S, Jerman I. 2013 The principle of coherence in multi-level brain information processing. Progr. Biophys. Mol. Biol. 111, 8-29. (doi:10.1016/j.pbiomolbio.2012.08.006)